Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus
about
Going wild: lessons from naturally occurring T-lymphotropic lentivirusesA detailed phylogenetic analysis of FIV in the United States.Feline immunodeficiency virus-infected cat sera associated with the development of broad neutralization resistance in vivo drive similar reversions in vitro.Adoptive immunotherapy of feline immunodeficiency virus with autologous ex vivo-stimulated lymphoid cells modulates virus and T-cell subsets in blood.Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence.Vaccine protection against feline immunodeficiency virus: setting the challenge.AIDS vaccination studies with an ex vivo feline immunodeficiency virus model: analysis of the accessory ORF-A protein and DNA as protective immunogensDynamics of viral and proviral loads of feline immunodeficiency virus within the feline central nervous system during the acute phase following intravenous infection.AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: protection from an intraclade challenge administered systemically or mucosally by an attenuated vaccine.Advances in FIV vaccine technology.Feline immunodeficiency virus model for designing HIV/AIDS vaccines.Sequence variation of the feline immunodeficiency virus genome and its clinical relevance.AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: reevaluation of neutralizing antibody levels elicited by a protective and a nonprotective vaccine after removal of antisubstrate cell antibodies.Modulation of the virus-receptor interaction by mutations in the V5 loop of feline immunodeficiency virus (FIV) following in vivo escape from neutralising antibodyVaccination with an inactivated virulent feline immunodeficiency virus engineered to express high levels of Env.Identification of a novel subtype of feline immunodeficiency virus in a population of naturally infected felines in the Brazilian Federal District.
P2860
Q31066870-23288328-6B48-45F0-8B9E-CEA380C10C26Q33658513-B0A3585E-F9F6-49B4-8F0A-092E3F859910Q33854938-E203A38B-B007-4289-9655-287177FBE91FQ33856528-2D8EFF64-2275-41FF-8979-23618B344375Q34339634-6BF5E7F3-FD80-4346-BA12-3AFB3FBB9B0EQ34575552-C08F3464-5922-4106-A921-36DECF3BFAE3Q35024266-155BFA00-7A5E-4625-8056-668624CD9E25Q35149650-24D98D97-C730-4774-988B-5BD0BD7E730CQ36473694-0EE275CB-0555-4540-B40C-8D8DB9803615Q36634847-BF590925-2431-43AA-9B9A-439FE73A3259Q37704546-461A68C2-4ADF-433D-AE05-7AA9571E8B35Q38113162-0AFC2BD7-B252-4B39-9F2B-F28B5C5E720AQ39602555-9ECE053A-476E-4486-87CF-06CD37FE3DB6Q40653669-EA11EFF7-0E79-4B7D-89DF-3EBA35C9AE35Q40893837-0D9456B6-BB2A-4EC6-ACD7-70D480ED77F1Q44209040-19F601A1-9C89-48D7-9B4C-DCDB9E448F1B
P2860
Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Vaccination with inactivated v ...... feline immunodeficiency virus
@en
Vaccination with inactivated v ...... feline immunodeficiency virus.
@nl
type
label
Vaccination with inactivated v ...... feline immunodeficiency virus
@en
Vaccination with inactivated v ...... feline immunodeficiency virus.
@nl
prefLabel
Vaccination with inactivated v ...... feline immunodeficiency virus
@en
Vaccination with inactivated v ...... feline immunodeficiency virus.
@nl
P2093
P2860
P1433
P1476
Vaccination with inactivated v ...... feline immunodeficiency virus
@en
P2093
Dunsford T
Macdonald J
P2860
P304
P356
10.1128/JVI.74.20.9403-9411.2000
P407
P577
2000-10-01T00:00:00Z